"Recognized nationally as a leader in cancer research, care and education, we are breaking barriers to beat cancer."

During the past decade, University of California Davis Comprehensive Cancer Center conducted 372 clinical trials. In the 10-year time frame, 372 clinical trials started and 279 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 133 clinical trials started and 127 clinical trials were completed. i.e. 95.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California Davis Comprehensive Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 252 trials, followed by "SWOG Cancer Research Network" with 109 trials sponsored, "Children's Oncology Group" with 83 trials sponsored, "University of California, Davis" with 57 trials sponsored and "Radiation Therapy Oncology Group" with 57 trials sponsored. Other sponsors include 257 different institutions and companies that sponsored additional 110 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California Davis Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 375 trials as a collaborator, "NRG Oncology" with 40 trials as a collaborator, "Cancer and Leukemia Group B" with 20 trials as a collaborator, "SWOG Cancer Research Network" with 17 trials as a collaborator and "Eastern Cooperative Oncology Group" with 14 trials as a collaborator. Other collaborators include 241 different institutions and companies that were collaborators in the rest 145 trials.

According to Clinical.Site data, the most researched conditions in "University of California Davis Comprehensive Cancer Center" are "Lung Cancer" (43 trials), "Breast Cancer" (36 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (32 trials), "Prostate Cancer" (26 trials) and "Leukemia" (20 trials). Many other conditions were trialed in "University of California Davis Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "University of California Davis Comprehensive Cancer Center" are "Drug" (661 trials), "Other" (286 trials), "Biological" (233 trials), "Procedure" (173 trials) and "Radiation" (166 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (166 trials), "Quality-of-Life Assessment" (71 trials), "Biospecimen Collection" (61 trials), "Computed Tomography" (54 trials) and "Pharmacological Study" (53 trials). Other intervention names were less common.

The vast majority of trials in "University of California Davis Comprehensive Cancer Center" are 662 trials for "All" genders, 75 trials for "Female" genders and 56 trials for "Male" genders.

Currently, there are 372 active trials in "University of California Davis Comprehensive Cancer Center". 1 are not yet recruiting, 139 are recruiting, 230 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 335 completed trials in University of California Davis Comprehensive Cancer Center, 10 suspended trials, and 58 terminated clinical trials to date.

Out of the total trials that were conducted in University of California Davis Comprehensive Cancer Center, 175 "Phase 1" clinical trials were conducted, 378 "Phase 2" clinical trials and 267 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 18 trials that are defined as “Not Applicable".